Industry Research Reports

Home > Reports > Chemical & Material > Global Ambrisentan Market Outlook, In‑Depth Analysis & Forecast to 2031

Global Ambrisentan Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Chemical & Material

Published Date: 2025-10-26

Pages: 146 Pages

Report ld: 5281057

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Ambrisentan market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Ambrisentan is used to treat symptoms of pulmonary arterial hypertension, which is high blood pressure in the main artery that carries blood from the right side of the heart (the ventricle) to the lungs, to improve your ability to exercise and slow down the worsening of your condition.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Ambrisentan market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Megafine
Yichang Tianren Pharmaceutical
Confucius Pharmceutical
Gilead Sciences
Cipla
MSN Laboratories

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

≥ 99%
＜ 99%

Segment by Application

Pulmonary Hypertension Phase II

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Ambrisentan study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.

Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.

Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.

Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.

Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.

Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.

Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles

Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.

Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.

Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 15: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Ambrisentan: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Ambrisentan Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 ≥ 99%

1.2.3 ＜ 99%

1.3 Market Segmentation by Application

1.3.1 Global Ambrisentan Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pulmonary Hypertension Phase II

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Ambrisentan Revenue Estimates and Forecasts 2020-2031

2.2 Global Ambrisentan Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Ambrisentan Sales Estimates and Forecasts 2020-2031

2.4 Global Ambrisentan Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Global Production Analysis

3.1 Global Ambrisentan Production Capacity and Utilization Rates (2020–2031)

3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)

3.3 Regional Production Dynamics

3.3.1 Historic Production by Region (2020-2025)

3.3.2 Forecasted Production by Region (2026-2031)

3.3.3 Production Market Share by Region (2020-2031)

3.3.4 Regulatory and Trade Policy Impact on Production

3.3.5 Production Capacity Enablers and Constraints

3.4 Key Regional Production Hubs

3.4.1 North America

3.4.2 Europe

3.4.3 China

3.4.4 Japan

4 Competition by Manufacturers

4.1 Global Ambrisentan Sales by Manufacturers

4.1.1 Global Sales Volume by Manufacturers (2020-2025)

4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

4.2 Global Ambrisentan Manufacturer Revenue Rankings and Tiers

4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

4.3 Manufacturer Profitability Profiles and Pricing Strategies

4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

4.3.2 Manufacturer-Level Price Trends (2020-2025)

4.4 Key Manufacturers Manufacturing Base and Headquarters

4.5 Main Product Type Market Size by Manufacturers

4.5.1 ≥ 99% Market Size by Manufacturers

4.5.2 ＜ 99% Market Size by Manufacturers

4.6 Global Ambrisentan Market Concentration and Dynamics

4.6.1 Global Market Concentration (CR5 and HHI)

4.6.2 Entrant/Exit Impact Analysis

4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

5 Global Product Segmentation Analysis

5.1 Global Ambrisentan Sales Performance by Type

5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

5.1.2 Global Sales Market Share by Type (2020-2031)

5.2 Global Ambrisentan Revenue Trends by Type

5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

5.2.2 Global Revenue Market Share by Type (2020-2031)

5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

5.4 Product Technology Differentiation

5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

5.5.1 High-Growth Niches and Adoption Drivers

5.5.2 Profitability Hotspots and Cost Drivers

5.5.3 Substitution Threats

6 Global Downstream Application Analysis

6.1 Global Ambrisentan Sales by Application

6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

6.1.2 Global Sales Market Share by Application (2020-2031)

6.1.3 High-Growth Application Identification

6.1.4 Emerging Application Case Studies

6.2 Global Ambrisentan Revenue by Application

6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

6.2.2 Revenue Market Share by Application (2020-2031)

6.3 Global Pricing Dynamics by Application (2020-2031)

6.4 Downstream Customer Analysis

6.4.1 Top Customers by Region

6.4.2 Top Customers by Application

7 North America

7.1 North America Sales Volume and Revenue (2020-2031)

7.2 North America Key Manufacturers Sales Revenue in 2024

7.3 North America Ambrisentan Sales and Revenue by Type (2020-2031)

7.4 North America Ambrisentan Sales and Revenue by Application (2020-2031)

7.5 North America Growth Accelerators and Market Barriers

7.6 North America Ambrisentan Market Size by Country

7.6.1 North America Revenue by Country

7.6.2 North America Sales Trends by Country

7.6.3 US

7.6.4 Canada

7.6.5 Mexico

8 Europe

8.1 Europe Sales Volume and Revenue (2020-2031)

8.2 Europe Key Manufacturers Sales Revenue in 2024

8.3 Europe Ambrisentan Sales and Revenue by Type (2020-2031)

8.4 Europe Ambrisentan Sales and Revenue by Application (2020-2031)

8.5 Europe Growth Accelerators and Market Barriers

8.6 Europe Ambrisentan Market Size by Country

8.6.1 Europe Revenue by Country

8.6.2 Europe Sales Trends by Country

8.6.3 Germany

8.6.4 France

8.6.5 U.K.

8.6.6 Italy

8.6.7 Russia

9 Asia-Pacific

9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

9.3 Asia-Pacific Ambrisentan Sales and Revenue by Type (2020-2031)

9.4 Asia-Pacific Ambrisentan Sales and Revenue by Application (2020-2031)

9.5 Asia-Pacific Ambrisentan Market Size by Region

9.5.1 Asia-Pacific Revenue by Region

9.5.2 Asia-Pacific Sales Trends by Region

9.6 Asia-Pacific Growth Accelerators and Market Barriers

9.7 Southeast Asia

9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand

9.8 China

9.9 Japan

9.10 South Korea

9.11 China Taiwan

9.12 India

10 Central and South America

10.1 Central and South America Sales Volume and Revenue (2020-2031)

10.2 Central and South America Key Manufacturers Sales Revenue in 2024

10.3 Central and South America Ambrisentan Sales and Revenue by Type (2020-2031)

10.4 Central and South America Ambrisentan Sales and Revenue by Application (2020-2031)

10.5 Central and South America Investment Opportunities and Key Challenges

10.6 Central and South America Ambrisentan Market Size by Country

10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 Brazil

10.6.3 Argentina

11 Middle East and Africa

11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

11.3 Middle East and Africa Ambrisentan Sales and Revenue by Type (2020-2031)

11.4 Middle East and Africa Ambrisentan Sales and Revenue by Application (2020-2031)

11.5 Middle East and Africa Investment Opportunities and Key Challenges

11.6 Middle East and Africa Ambrisentan Market Size by Country

11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

11.6.2 GCC Countries

11.6.3 Turkey

11.6.4 Egypt

11.6.5 South Africa

12 Corporate Profile

12.1 Megafine

12.1.1 Megafine Corporation Information

12.1.2 Megafine Business Overview

12.1.3 Megafine Ambrisentan Product Models, Descriptions and Specifications

12.1.4 Megafine Ambrisentan Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.1.5 Megafine Ambrisentan Sales by Product in 2024

12.1.6 Megafine Ambrisentan Sales by Application in 2024

12.1.7 Megafine Ambrisentan Sales by Geographic Area in 2024

12.1.8 Megafine Ambrisentan SWOT Analysis

12.1.9 Megafine Recent Developments

12.2 Yichang Tianren Pharmaceutical

12.2.1 Yichang Tianren Pharmaceutical Corporation Information

12.2.2 Yichang Tianren Pharmaceutical Business Overview

12.2.3 Yichang Tianren Pharmaceutical Ambrisentan Product Models, Descriptions and Specifications

12.2.4 Yichang Tianren Pharmaceutical Ambrisentan Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.2.5 Yichang Tianren Pharmaceutical Ambrisentan Sales by Product in 2024

12.2.6 Yichang Tianren Pharmaceutical Ambrisentan Sales by Application in 2024

12.2.7 Yichang Tianren Pharmaceutical Ambrisentan Sales by Geographic Area in 2024

12.2.8 Yichang Tianren Pharmaceutical Ambrisentan SWOT Analysis

12.2.9 Yichang Tianren Pharmaceutical Recent Developments

12.3 Confucius Pharmceutical

12.3.1 Confucius Pharmceutical Corporation Information

12.3.2 Confucius Pharmceutical Business Overview

12.3.3 Confucius Pharmceutical Ambrisentan Product Models, Descriptions and Specifications

12.3.4 Confucius Pharmceutical Ambrisentan Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.3.5 Confucius Pharmceutical Ambrisentan Sales by Product in 2024

12.3.6 Confucius Pharmceutical Ambrisentan Sales by Application in 2024

12.3.7 Confucius Pharmceutical Ambrisentan Sales by Geographic Area in 2024

12.3.8 Confucius Pharmceutical Ambrisentan SWOT Analysis

12.3.9 Confucius Pharmceutical Recent Developments

12.4 Gilead Sciences

12.4.1 Gilead Sciences Corporation Information

12.4.2 Gilead Sciences Business Overview

12.4.3 Gilead Sciences Ambrisentan Product Models, Descriptions and Specifications

12.4.4 Gilead Sciences Ambrisentan Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.4.5 Gilead Sciences Ambrisentan Sales by Product in 2024

12.4.6 Gilead Sciences Ambrisentan Sales by Application in 2024

12.4.7 Gilead Sciences Ambrisentan Sales by Geographic Area in 2024

12.4.8 Gilead Sciences Ambrisentan SWOT Analysis

12.4.9 Gilead Sciences Recent Developments

12.5 Cipla

12.5.1 Cipla Corporation Information

12.5.2 Cipla Business Overview

12.5.3 Cipla Ambrisentan Product Models, Descriptions and Specifications

12.5.4 Cipla Ambrisentan Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.5.5 Cipla Ambrisentan Sales by Product in 2024

12.5.6 Cipla Ambrisentan Sales by Application in 2024

12.5.7 Cipla Ambrisentan Sales by Geographic Area in 2024

12.5.8 Cipla Ambrisentan SWOT Analysis

12.5.9 Cipla Recent Developments

12.6 MSN Laboratories

12.6.1 MSN Laboratories Corporation Information

12.6.2 MSN Laboratories Business Overview

12.6.3 MSN Laboratories Ambrisentan Product Models, Descriptions and Specifications

12.6.4 MSN Laboratories Ambrisentan Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)

12.6.5 MSN Laboratories Recent Developments

13 Value Chain and Supply-Chain Analysis

13.1 Ambrisentan Industry Chain

13.2 Ambrisentan Upstream Materials Analysis

13.2.1 Raw Materials

13.2.2 Key Suppliers Market Share & Risk Assessment

13.3 Ambrisentan Integrated Production Analysis

13.3.1 Manufacturing Footprint Analysis

13.3.2 Production Technology Overview

13.3.3 Regional Cost Drivers

13.4 Ambrisentan Sales Channels and Distribution Networks

13.4.1 Sales Channels

13.4.2 Distributors

14 Ambrisentan Market Dynamics

14.1 Industry Trends and Evolution

14.2 Market Growth Drivers and Emerging Opportunities

14.3 Market Challenges, Risks, and Restraints

15 Key Findings in the Global Ambrisentan Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.1.1 Research Programs/Design

16.1.1.2 Market Size Estimation

16.1.1.3 Market Breakdown and Data Triangulation

16.1.2 Data Source

16.1.2.1 Secondary Sources

16.1.2.2 Primary Sources

16.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Ambrisentan Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Ambrisentan Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Ambrisentan Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Ambrisentan Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Ambrisentan Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Ambrisentan Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 7. Global Ambrisentan Sales by Region (2020-2025) & (MT)

Table 8. Global Ambrisentan Sales by Region (2026-2031) & (MT)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Ambrisentan Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)

Table 11. Global Ambrisentan Production by Region (2020-2025) & (MT)

Table 12. Global Ambrisentan Production by Region (2026-2031) & (MT)

Table 13. Global Ambrisentan Sales by Manufacturers (2020-2025) & (MT)

Table 14. Global Ambrisentan Sales Share by Manufacturers (2020-2025)

Table 15. Global Ambrisentan Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 16. Global Ambrisentan Revenue Market Share by Manufacturers (2020-2025)

Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 18. Global Ambrisentan by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambrisentan as of 2024)

Table 19. Global Ambrisentan Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 20. Global Ambrisentan Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Kg)

Table 21. Key Manufacturers Ambrisentan Manufacturing Base and Headquarters

Table 22. Global Ambrisentan Market Concentration Ratio (CR5 and HHI)

Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 25. Global Ambrisentan Sales by Type (2020-2025) & (MT)

Table 26. Global Ambrisentan Sales by Type (2026-2031) & (MT)

Table 27. Global Ambrisentan Revenue by Type (2020-2025) & (US$ Million)

Table 28. Global Ambrisentan Revenue by Type (2026-2031) & (US$ Million)

Table 29. Global Ambrisentan ASP by Type (2020-2031) & (USD/Kg)

Table 30. Technical Specifications by Key Product Type

Table 31. Global Ambrisentan Sales by Application (2020-2025) & (MT)

Table 32. Global Ambrisentan Sales by Application (2026-2031) & (MT)

Table 33. Ambrisentan High-Growth Sectors Demand CAGR (2024-2031)

Table 34. Global Ambrisentan Revenue by Application (2020-2025) & (US$ Million)

Table 35. Global Ambrisentan Revenue by Application (2026-2031) & (US$ Million)

Table 36. Global Ambrisentan ASP by Application (2020-2031) & (USD/Kg)

Table 37. Top Customers by Region

Table 38. Top Customers by Application

Table 39. North America Ambrisentan Growth Accelerators and Market Barriers

Table 40. North America Ambrisentan Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 41. North America Ambrisentan Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 42. Europe Ambrisentan Growth Accelerators and Market Barriers

Table 43. Europe Ambrisentan Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 44. Europe Ambrisentan Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 45. Asia-Pacific Ambrisentan Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Asia-Pacific Ambrisentan Sales (MT) by Country (2020 VS 2024 VS 2031)

Table 47. Asia-Pacific Ambrisentan Growth Accelerators and Market Barriers

Table 48. Southeast Asia Ambrisentan Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 49. Central and South America Ambrisentan Investment Opportunities and Key Challenges

Table 50. Central and South America Ambrisentan Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 51. Middle East and Africa Ambrisentan Investment Opportunities and Key Challenges

Table 52. Middle East and Africa Ambrisentan Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 53. Megafine Corporation Information

Table 54. Megafine Description and Major Businesses

Table 55. Megafine Product Models, Descriptions and Specifications

Table 56. Megafine Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 57. Megafine Sales Value Proportion by Product in 2024

Table 58. Megafine Sales Value Proportion by Application in 2024

Table 59. Megafine Sales Value Proportion by Geographic Area in 2024

Table 60. Megafine Ambrisentan SWOT Analysis

Table 61. Megafine Recent Developments

Table 62. Yichang Tianren Pharmaceutical Corporation Information

Table 63. Yichang Tianren Pharmaceutical Description and Major Businesses

Table 64. Yichang Tianren Pharmaceutical Product Models, Descriptions and Specifications

Table 65. Yichang Tianren Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 66. Yichang Tianren Pharmaceutical Sales Value Proportion by Product in 2024

Table 67. Yichang Tianren Pharmaceutical Sales Value Proportion by Application in 2024

Table 68. Yichang Tianren Pharmaceutical Sales Value Proportion by Geographic Area in 2024

Table 69. Yichang Tianren Pharmaceutical Ambrisentan SWOT Analysis

Table 70. Yichang Tianren Pharmaceutical Recent Developments

Table 71. Confucius Pharmceutical Corporation Information

Table 72. Confucius Pharmceutical Description and Major Businesses

Table 73. Confucius Pharmceutical Product Models, Descriptions and Specifications

Table 74. Confucius Pharmceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 75. Confucius Pharmceutical Sales Value Proportion by Product in 2024

Table 76. Confucius Pharmceutical Sales Value Proportion by Application in 2024

Table 77. Confucius Pharmceutical Sales Value Proportion by Geographic Area in 2024

Table 78. Confucius Pharmceutical Ambrisentan SWOT Analysis

Table 79. Confucius Pharmceutical Recent Developments

Table 80. Gilead Sciences Corporation Information

Table 81. Gilead Sciences Description and Major Businesses

Table 82. Gilead Sciences Product Models, Descriptions and Specifications

Table 83. Gilead Sciences Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 84. Gilead Sciences Sales Value Proportion by Product in 2024

Table 85. Gilead Sciences Sales Value Proportion by Application in 2024

Table 86. Gilead Sciences Sales Value Proportion by Geographic Area in 2024

Table 87. Gilead Sciences Ambrisentan SWOT Analysis

Table 88. Gilead Sciences Recent Developments

Table 89. Cipla Corporation Information

Table 90. Cipla Description and Major Businesses

Table 91. Cipla Product Models, Descriptions and Specifications

Table 92. Cipla Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 93. Cipla Sales Value Proportion by Product in 2024

Table 94. Cipla Sales Value Proportion by Application in 2024

Table 95. Cipla Sales Value Proportion by Geographic Area in 2024

Table 96. Cipla Ambrisentan SWOT Analysis

Table 97. Cipla Recent Developments

Table 98. MSN Laboratories Corporation Information

Table 99. MSN Laboratories Description and Major Businesses

Table 100. MSN Laboratories Product Models, Descriptions and Specifications

Table 101. MSN Laboratories Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)

Table 102. MSN Laboratories Recent Developments

Table 103. Key Raw Materials Distribution

Table 104. Raw Materials Key Suppliers

Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 106. Milestones in Production Technology Evolution

Table 107. Distributors List

Table 108. Market Trends and Market Evolution

Table 109. Market Drivers and Opportunities

Table 110. Market Challenges, Risks, and Restraints

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Ambrisentan Product Picture

Figure 2. Global Ambrisentan Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. ≥ 99% Product Picture

Figure 4. ＜ 99% Product Picture

Figure 5. Global Ambrisentan Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Pulmonary Hypertension Phase II

Figure 7. Ambrisentan Report Years Considered

Figure 8. Global Ambrisentan Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 9. Global Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 10. Global Ambrisentan Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 11. Global Ambrisentan Revenue Market Share by Region (2020-2031)

Figure 12. Global Ambrisentan Sales (2020-2031) & (MT)

Figure 13. Global Ambrisentan Sales (CAGR) by Region (2020-2031) (MT)

Figure 14. Global Ambrisentan Sales Market Share by Region (2020-2031)

Figure 15. Global Ambrisentan Capacity, Production and Utilization (2020-2031) & (MT)

Figure 16. Global Ambrisentan Production Trend by Region (2020-2031) (MT)

Figure 17. Global Ambrisentan Production Market Share by Region (2020-2031)

Figure 18. Production Capacity Enablers & Constraints

Figure 19. Ambrisentan Production Growth Rate in North America (2020-2031) & (MT)

Figure 20. Ambrisentan Production Growth Rate in Europe (2020-2031) & (MT)

Figure 21. Ambrisentan Production Growth Rate in China (2020-2031) & (MT)

Figure 22. Ambrisentan Production Growth Rate in Japan (2020-2031) & (MT)

Figure 23. Top 5 and Top 10 Manufacturers Ambrisentan Sales Volume Market Share in 2024

Figure 24. Global Ambrisentan Revenue Market Share Ranking (2024)

Figure 25. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 26. ≥ 99% Revenue Market Share by Manufacturer in 2024

Figure 27. ＜ 99% Revenue Market Share by Manufacturer in 2024

Figure 28. Type Eight Revenue Market Share by Manufacturer in 2024

Figure 29. Type Nine Revenue Market Share by Manufacturer in 2024

Figure 30. Global Ambrisentan Sales Market Share by Type (2020-2031)

Figure 31. Global Ambrisentan Revenue Market Share by Type (2020-2031)

Figure 32. Global Ambrisentan Sales Market Share by Application (2020-2031)

Figure 33. Global Ambrisentan Revenue Market Share by Application (2020-2031)

Figure 34. North America Ambrisentan Sales YoY (2020-2031) & (MT)

Figure 35. North America Ambrisentan Revenue YoY (2020-2031) & (US$ Million)

Figure 36. North America Top 5 Manufacturers Ambrisentan Sales Revenue (US$ Million) in 2024

Figure 37. North America Ambrisentan Sales Volume (MT) by Type (2020- 2031)

Figure 38. North America Ambrisentan Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 39. North America Ambrisentan Sales Volume (MT) by Application (2020-2031)

Figure 40. North America Ambrisentan Sales Revenue (US$ Million) by Application (2020-2031)

Figure 41. US Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 42. Canada Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 43. Mexico Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 44. Europe Ambrisentan Sales YoY (2020-2031) & (MT)

Figure 45. Europe Ambrisentan Revenue YoY (2020-2031) & (US$ Million)

Figure 46. Europe Top 5 Manufacturers Ambrisentan Sales Revenue (US$ Million) in 2024

Figure 47. Europe Ambrisentan Sales Volume (MT) by Type (2020-2031)

Figure 48. Europe Ambrisentan Sales Revenue (US$ Million) by Type (2020-2031)

Figure 49. Europe Ambrisentan Sales Volume (MT) by Application (2020-2031)

Figure 50. Europe Ambrisentan Sales Revenue (US$ Million) by Application (2020-2031)

Figure 51. Germany Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 52. France Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 53. U.K. Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 54. Italy Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 55. Russia Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 56. Asia-Pacific Ambrisentan Sales YoY (2020-2031) & (MT)

Figure 57. Asia-Pacific Ambrisentan Revenue YoY (2020-2031) & (US$ Million)

Figure 58. Asia-Pacific Top 8 Manufacturers Ambrisentan Sales Revenue (US$ Million) in 2024

Figure 59. Asia-Pacific Ambrisentan Sales Volume (MT) by Type (2020- 2031)

Figure 60. Asia-Pacific Ambrisentan Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 61. Asia-Pacific Ambrisentan Sales Volume (MT) by Application (2020-2031)

Figure 62. Asia-Pacific Ambrisentan Sales Revenue (US$ Million) by Application (2020-2031)

Figure 63. Indonesia Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 64. Japan Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 65. South Korea Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 66. China Taiwan Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 67. India Ambrisentan Revenue (2020-2031) & (US$ Million)

Figure 68. Central and South America Ambrisentan Sales YoY (2020-2031) & (MT)

Figure 69. Central and South America Ambrisentan Revenue YoY (2020-2031) & (US$ Million)

Figure 70. Central and South America Top 5 Manufacturers Ambrisentan Sales Revenue (US$ Million) in 2024

Figure 71. Central and South America Ambrisentan Sales Volume (MT) by Type (2021-2031)

Figure 72. Central and South America Ambrisentan Sales Revenue (US$ Million) by Type (2020-2031)

Figure 73. Central and South America Ambrisentan Sales Volume (MT) by Application (2020-2031)

Figure 74. Central and South America Ambrisentan Sales Revenue (US$ Million) by Application (2020-2031)

Figure 75. Brazil Ambrisentan Revenue (2020-2025) & (US$ Million)

Figure 76. Argentina Ambrisentan Revenue (2020-2025) & (US$ Million)

Figure 77. Middle East, and Africa Ambrisentan Sales YoY (2020-2031) & (MT)

Figure 78. Middle East and Africa Ambrisentan Revenue YoY (2020-2031) & (US$ Million)

Figure 79. Middle East and Africa Top 5 Manufacturers Ambrisentan Sales Revenue (US$ Million) in 2024

Figure 80. Middle East and Africa Ambrisentan Sales Volume (MT) by Type (2021-2031)

Figure 81. South America Ambrisentan Sales Revenue (US$ Million) by Type (2020-2031)

Figure 82. Middle East and Africa Ambrisentan Sales Volume (MT) by Application (2020-2031)

Figure 83. Middle East and Africa Ambrisentan Sales Revenue (US$ Million) by Application (2020-2031)

Figure 84. GCC Countries Ambrisentan Revenue (2020-2025) & (US$ Million)

Figure 85. Turkey Ambrisentan Revenue (2020-2025) & (US$ Million)

Figure 86. Egypt Ambrisentan Revenue (2020-2025) & (US$ Million)

Figure 87. South Africa Ambrisentan Revenue (2020-2025) & (US$ Million)

Figure 88. Ambrisentan Industry Chain Mapping

Figure 89. Regional Ambrisentan Manufacturing Base Distribution (%)

Figure 90. Ambrisentan Production Process

Figure 91. Regional Ambrisentan Production Cost Structure

Figure 92. Channels of Distribution (Direct Vs Distribution)

Figure 93. Bottom-up and Top-down Approaches for This Report

Figure 94. Data Triangulation

Figure 95. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Ambrisentan market? zhanKai

The top companies in the global Ambrisentan market are Megafine、Yichang Tianren Pharmaceutical、Confucius Pharmceutical.

Related Reports

Ambrisentan- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ambrisentan was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 134
USD 3950.00
(Single User License)
Global Ambrisentan Market Research Report 2026
The global Ambrisentan market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 127
USD 2900.00
(Single User License)
Global Ambrisentan Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ambrisentan market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 76
USD 4250.00
(Single User License)
Ambrisentan- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ambrisentan was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 103
USD 3950.00
(Single User License)
Global Ambrisentan Market Research Report 2025
The global market for Ambrisentan was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 89
USD 2900.00
(Single User License)
Ambrisentan - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Ambrisentan was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-24
Pages: 99
USD 3950.00
(Single User License)
Global Ambrisentan Market Research Report 2024
The global Ambrisentan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-04
Pages: 86
USD 2900.00
(Single User License)

Ambrisentan- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Ambrisentan was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 134
USD 3950.00 (Single User License)
Global Ambrisentan Market Research Report 2026
The global Ambrisentan market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 127
USD 2900.00 (Single User License)
Global Ambrisentan Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Ambrisentan market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 76
USD 4250.00 (Single User License)
Ambrisentan- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Ambrisentan was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 103
USD 3950.00 (Single User License)
Global Ambrisentan Market Research Report 2025
The global market for Ambrisentan was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 89
USD 2900.00 (Single User License)
Ambrisentan - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Ambrisentan was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-24
Pages: 99
USD 3950.00 (Single User License)
Global Ambrisentan Market Research Report 2024
The global Ambrisentan market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-04
Pages: 86
USD 2900.00 (Single User License)